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Background
T2* Magnetic Resonance Imaging (MRI) technique allows
noninvasive quantification of organ-specific iron burden,
playing a key role in the management of thalassemia
major (TM) patients. There are few data on the incidence
of heart failure and arrhythmias in TM patients according
to baseline T2* values. So, the aim of this study was to
establish prospectively the risk of cardiac complications in
a large cohort of well-treated TM patients.
Methods
We considered 527 TM patients (252 males, mean age
30±9) for who clinical data relative to a period of 5
years after the first MRI were collected in a central data
base. At time of the first scan mean ferritin levels
were1653±1559 ng/l, global heart was 27±13 ms, and
excellent/good level of compliance were present in the
96% of the study population.
Results
At 5 years of follow-up, we recorded 24 cardiac events:
4 episodes of cardiac failure, 15 of arrhythmia, 1 of pul-
monary hypertension and 4 of other cardiac complica-
tions. The majority of these events (21/24) happened
within the first 24 months subsequent to the MRI, so
we considered this follow-up period.
At the first MRI scan, in patients with cardiac compli-
cations the global heart T2* was 22.5 ±12.4 ms. In com-
parison with global heart T2* values ≥20 ms, there was
not a significantly increased risk of cardiac complica-
tions associated with global heart T2* values <20 ms
(HR= 2.028 P=0.09).
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19±12 ms. In comparison with global heart T2* values
≥20 ms, there was not a significantly increased risk of
heart failure associated with global heart T2* values <20
ms (HR=1.9 P=0.524) or <10 ms (HR=2.6 P=0.443).
In the arrhythmic patients the global heart T2* was 25
±13 ms. In comparison with global heart T2* values ≥20
ms, there was not a significantly increased risk of
arrhythmia associated with global heart T2* values <20
ms (HR=2.1 P=0.179) or <10 ms (HR=0.8 P=0.824).
During the follow up changes in the chelation therapy
(type and/or dose-frequencies) were found in > 25% of
the study population.
Conclusions
We detected very few cardiac events, almost all concen-
trated in the first 24 months. In a large cohort of well-
treated TM patients heart T2* lost its power in predict-
ing cardiac events probably due to a patient-specific
adjustment of the chelation therapy MRI-guided.
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